Literature DB >> 29728759

Effectiveness of gabapentin as a postoperative analgesic in children undergoing appendectomy.

Katherine J Baxter1, Jennifer Hafling2, Jennifer Sterner2, Adarsh U Patel1, Helen Giannopoulos2, Kurt F Heiss1, Mehul V Raval3.   

Abstract

PURPOSE: Though gabapentin is increasingly used as a perioperative analgesic, data regarding effectiveness in children are limited. The purpose of this study was to evaluate gabapentin as a postoperative analgesic in children undergoing appendectomy.
METHODS: A 12-month retrospective review of children undergoing appendectomy was performed at a two-hospital children's institution. Patients receiving gabapentin (GP) were matched (1:2) with patients who did not receive gabapentin (NG) based on age, sex and appendicitis severity. Outcome measures included postoperative opioid use, pain scores, and revisits/readmissions.
RESULTS: We matched 29 (33.3%) GP patients with 58 (66.6%) NG patients (n = 87). The GP group required significantly less postoperative opioids than the NG group (0.034 mg morphine equivalents/kg (ME/kg) vs. 0.106 ME/kg, p < 0.01). Groups had similar lengths of time from operation to pain scores ≤ 3 (GP 12.21 vs. NG 17.01 h, p = 0.23). GP and NG had similar rates of revisit to the emergency department (13.8 vs. 10.3%, p = 0.73), readmission (6.9 vs. 1.7%, p = 0.26), and revisits secondary to surgical pain (3.4 vs. 3.4%, p = 1.00).
CONCLUSION: In this single-center, retrospective cohort study, gabapentin is associated with a reduction in total postoperative opioid use in children with appendicitis. While promising, further prospective validation of clinical effectiveness is needed.

Entities:  

Keywords:  Abdominal surgery; Analgesic; Appendectomy; Gabapentin; Opioid epidemic

Mesh:

Substances:

Year:  2018        PMID: 29728759     DOI: 10.1007/s00383-018-4274-9

Source DB:  PubMed          Journal:  Pediatr Surg Int        ISSN: 0179-0358            Impact factor:   1.827


  25 in total

1.  Gabapentin significantly decreases posthemorrhoidectomy pain: a prospective study.

Authors:  Vitaliy Poylin; Jeanne Quinn; Kristin Messer; Deborah Nagle
Journal:  Int J Colorectal Dis       Date:  2014-10-01       Impact factor: 2.571

2.  Single-dose gabapentin pharmacokinetics and safety in healthy infants and children.

Authors:  G M Haig; H N Bockbrader; D L Wesche; S W Boellner; D Ouellet; R R Brown; E J Randinitis; E L Posvar
Journal:  J Clin Pharmacol       Date:  2001-05       Impact factor: 3.126

3.  A Comparison of Multimodal Analgesic Approaches in Institutional Enhanced Recovery After Surgery Protocols for Colorectal Surgery: Pharmacological Agents.

Authors:  Erik M Helander; Michael P Webb; Meghan Bias; Edward E Whang; Alan D Kaye; Richard D Urman
Journal:  J Laparoendosc Adv Surg Tech A       Date:  2017-07-25       Impact factor: 1.878

4.  Implementation of an enhanced recovery protocol in pediatric colorectal surgery.

Authors:  Heather L Short; Kurt F Heiss; Katelyn Burch; Curtis Travers; John Edney; Claudia Venable; Mehul V Raval
Journal:  J Pediatr Surg       Date:  2017-05-12       Impact factor: 2.545

5.  Opioid abuse and depression in adolescents: Results from the National Survey on Drug Use and Health.

Authors:  Mark J Edlund; Valerie L Forman-Hoffman; Cherie R Winder; David C Heller; Larry A Kroutil; Rachel N Lipari; Lisa J Colpe
Journal:  Drug Alcohol Depend       Date:  2015-04-22       Impact factor: 4.492

6.  Gabapentin use in pediatric spinal fusion patients: a randomized, double-blind, controlled trial.

Authors:  Lynn M Rusy; Keri R Hainsworth; Tom J Nelson; Michelle L Czarnecki; J Channing Tassone; John G Thometz; Roger M Lyon; Richard J Berens; Steven J Weisman
Journal:  Anesth Analg       Date:  2010-05-01       Impact factor: 5.108

7.  Outcomes after implementation of a multimodal standard care pathway for laparoscopic colorectal surgery.

Authors:  D W Larson; J K Lovely; R R Cima; E J Dozois; H Chua; B G Wolff; J H Pemberton; R R Devine; M Huebner
Journal:  Br J Surg       Date:  2014-05-15       Impact factor: 6.939

8.  Recognition and management of iatrogenically induced opioid dependence and withdrawal in children.

Authors:  Jeffrey Galinkin; Jeffrey Lee Koh
Journal:  Pediatrics       Date:  2013-12-30       Impact factor: 7.124

9.  Study of the effect of oral gabapentin used as preemptive analgesia to attenuate post-operative pain in patients undergoing abdominal surgery under general anesthesia.

Authors:  Harshel G Parikh; Sananta Kumar Dash; Chitra B Upasani
Journal:  Saudi J Anaesth       Date:  2010-09

10.  Gabapentin can decrease acute pain and morphine consumption in spinal surgery patients: A meta-analysis of randomized controlled trials.

Authors:  Chuangang Peng; Chen Li; Ji Qu; Dankai Wu
Journal:  Medicine (Baltimore)       Date:  2017-04       Impact factor: 1.889

View more
  3 in total

1.  Implementation and sustainability of an enhanced recovery pathway in pediatric bladder reconstruction: Flexibility, commitment, teamwork.

Authors:  Yvonne Y Chan; David I Chu; Josephine Hirsch; Soojin Kim; Ilina Rosoklija; Abbey Studer; Megan A Brockel; Earl Y Cheng; Mehul V Raval; Nicholas E Burjek; Kyle O Rove; Elizabeth B Yerkes
Journal:  J Pediatr Urol       Date:  2021-09-04       Impact factor: 1.830

2.  The impact of intravenous acetaminophen pricing on opioid utilization and outcomes for children with appendicitis.

Authors:  Elaa M Mahdi; Shadassa Ourshalimian; David Darcy; Christopher J Russell; Lorraine I Kelley-Quon
Journal:  Surgery       Date:  2021-05-10       Impact factor: 4.348

3.  Medical Management of Chronic Pancreatitis in Children: A Position Paper by the North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition Pancreas Committee.

Authors:  A Jay Freeman; Asim Maqbool; Melena D Bellin; Kenneth R Goldschneider; Amit S Grover; Cheryl Hartzell; Travis L Piester; Flora Szabo; Bridget Dowd Kiernan; Racha Khalaf; Rakesh Kumar; Mirta Rios; Sohail Z Husain; Veronique D Morinville; Maisam Abu-El-Haija
Journal:  J Pediatr Gastroenterol Nutr       Date:  2021-02-01       Impact factor: 3.288

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.